Tracking every rollback, reversal, and overreach — and the path back to the America we know.
Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana to a less-dangerous drug category under federal law. The change impacts federal regulation of marijuana in dozens of states that permit medical use, though it does not fully legalize marijuana federally. This significantly alters how the drug is regulated and enforced at the federal level.
President Trump selected Erica Schwartz, former deputy surgeon general and medical doctor, to lead the Centers for Disease Control and Prevention. Schwartz, a retired rear admiral in the U.S. Public Health Service Commissioned Corps, requires Senate confirmation. The CDC has been without permanent leadership for eight months.
President Trump nominated Kevin Warsh, head of the National Economic Council, to lead the Federal Reserve. The nomination is expected to advance to confirmation hearings with support from administration officials. If confirmed, Warsh would direct monetary policy affecting interest rates, inflation, and economic conditions for all Americans.
President Trump signed Executive Order 14178 on January 23, 2025, directing federal agencies to strengthen U.S. leadership in digital financial technology and cryptocurrency. The order establishes a framework for federal coordination on digital assets policy. Confirmed direct impacts on Americans include potential changes to how federal agencies regulate and oversee cryptocurrency transactions and digital finance activities.
The Federal Trade Commission and four states filed suit against the World Professional Association for Transgender Health, alleging deceptive claims about gender-affirming care for minors. The action targets medical professionals and organizations providing transgender healthcare services. This represents a coordinated federal and state effort to restrict access to gender-affirming medical care for transgender youth.
The Trump administration is proposing a government-wide non-disclosure agreement (NDA) requiring all federal workers to sign sweeping confidentiality agreements. Free speech and open government advocates have protested the proposal as unconstitutional, arguing it violates First Amendment protections and is compounded by concurrent workforce cuts and increased political control over federal employees. The action threatens government transparency and employee speech rights.
Defense Secretary Pete Hegseth stripped nine Navy officers—including women and Black service members—from a promotion list to admiral, resulting in an all-male, overwhelmingly white slate of 22 nominees. The intervention violated standard promotion procedures and represents a significant departure from military diversity standards. The action directly affects career advancement opportunities for minority and female officers seeking flag rank.
The Senate voted 54-45 to confirm Kevin Warsh as Federal Reserve chair, replacing Jerome Powell. Warsh will serve a four-year term overseeing monetary policy amid elevated inflation and Trump administration pressure to lower interest rates. The confirmation shifts Federal Reserve leadership toward an administration-preferred chair amid ongoing economic policy tensions.
The Education Department nullified six Title IX settlement agreements from the Obama and Biden administrations that required school districts to implement gender identity anti-discrimination policies. This action eliminates protections for transgender and gender-nonconforming students in schools across multiple districts. The move opens these settled cases to potential legal challenge and removes established safeguards against gender-based discrimination in education.
The Trump administration froze millions of dollars in federal funding for New York's Medicaid Fraud Control Unit (MFCU), which investigates and prosecutes healthcare provider fraud and patient abuse in Medicaid facilities. The action eliminates dedicated enforcement capacity for detecting fraud and protecting vulnerable patients in state Medicaid programs. New York loses federal resources for healthcare oversight and fraud prevention affecting thousands of Medicaid beneficiaries.